Cargando…
Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?
The management of locally advanced rectal cancer (LARC) requires multimodality treatment, typically with neoadjuvant chemoradiotherapy (CRT) followed by total mesorectal excision. However, the treatment landscape is rapidly evolving with total neoadjuvant therapy and non-operative management for sel...
Autores principales: | Piercey, Oliver, Tie, Jeanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017954/ https://www.ncbi.nlm.nih.gov/pubmed/36936200 http://dx.doi.org/10.1177/17588359231160138 |
Ejemplares similares
-
Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma
por: Topham, James T., et al.
Publicado: (2023) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
por: Solar Vasconcelos, Joao Paulo, et al.
Publicado: (2022) -
Circulating DNA in patients undergoing loco-regional treatment of
colorectal cancer metastases: a systematic review and
meta-analysis
por: Callesen, Louise B., et al.
Publicado: (2022) -
Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors –
can we RECIST? Focus on colorectal cancer
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023) -
Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer
por: Boutin, Mélina, et al.
Publicado: (2023)